denice johns created a new article
27 w

A greater dose of ivermectin will be tested in a research aimed at treating mild-to-moderate COVID-19. | #health

A greater dose of ivermectin will be tested in a research aimed at treating mild-to-moderate COVID-19.

A greater dose of ivermectin will be tested in a research aimed at treating mild-to-moderate COVID-19.

ACTIV-6, also known as "The Randomized Trial to Evaluate Efficacy of Repurposed Medications," is a double-blind, nationwide study that has attracted over 3,000 participants thus far. It is expected that enrollment will.